This session explores clinical approaches to alveolar ridge preservation and highlights how NOVAMag® SHIELD enables predictable bone regeneration through resorbable, space-maintaining support, eliminating the need for removal.
Achieving long-term functional and aesthetic success in implant therapy, particularly in the anterior maxilla, requires a comprehensive approach to both hard and soft tissue management. Following tooth extraction, the resorption of the buccal bone plate is a common biological event, posing a significant challenge to implant positioning and tissue stability.
In recent years, techniques aimed at preserving the bone wall have gained increasing attention. Among them, the Shield Technique has shown promising results in minimizing ridge collapse. However, in cases where the bone wall is already compromised or when additional support is needed, biomaterials play a crucial role in achieving predictable outcomes. A new generation of resorbable magnesium-based solutions offers a unique approach in these scenarios. Designed to provide mechanical support while gradually integrating into the healing site, NOVAMag® SHIELD maintains space and contour during the critical healing phase. Thus, the post-extraction defects are managed by preserving alveolar bone volume, thereby supporting the establishment of a stable foundation for long-term prosthetic rehabilitation.
The session will focus on current clinical strategies to preserve the alveolar ridge following tooth extraction. Participants will learn how NOVAMag® SHIELD enables predictable space maintenance and bone regeneration by providing temporary structural support while gradually resorbing in sync with the natural healing process, eliminating the need for secondary removal. In contrast to conventional techniques where regenerated bone may be prone to resorption over time, the application of NOVAMag® SHIELD promotes the formation of strong, high-quality bone, creating a stable foundation for long-term implant or bridge placement. Clinical indications, procedural steps and expected outcomes will be discussed in detail, providing attendees with practical insights for integrating this novel biomaterial into their daily practice.
Tribune Group GmbH Inc.